Novo Nordisk A/S (NVO) |
|
63.85 0.34 (0.54%)
|
02-21 16:02 |
|
Open: |
63.74 |
Pre. Close: |
63.51 |
|
High:
|
64.05 |
Low:
|
63.52 |
|
Volume:
|
873,502 |
Market Cap:
|
151303M |
|
|
|
|
Novo Nordisk A/S is a healthcare company. It is engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The company's business segments include, diabetes and obesity care, and biopharmaceuticals. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
64.122 - 64.377 |
64.377 - 64.596 |
|
Low:
|
62.807 - 63.125 |
63.125 - 63.399 |
|
Close:
|
63.305 - 63.82 |
63.82 - 64.263 |
|
Technical analysis |
as of: 2020-02-21 4:32:33 PM |
|
Overall:
|
 |
| Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 75.71 One year: 88.43 |
| Support: |
Support1: 61.71 Support2: 59.79 |
| Resistance: |
Resistance1: 64.82 Resistance2: 75.71 |
| Pivot: |
63.17  |
| Moving Average: |
MA(5): 63.81 MA(20): 62.52
MA(100): 57.36 MA(250): 52.99 |
| MACD: |
MACD(12,26): 1.12  Signal(9): 1.17 |
| Stochastic oscillator: |
%K(14,3): 76.64 %D(3): 78.96 |
| RSI: |
RSI(14): 61.95 |
| 52-week: |
High: 64.82 Low: 46.47 Change(%): 29.2 |
| Average Vol(K): |
3-Month: 131548 10-Days: 98106 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.NVO has closed below upper band by 35.1%. Bollinger Bands are 7.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Fri, 21 Feb 2020 18:55:00 +0000
A Plan to Use Blockchain to Stop Counterfeit Drugs Moves Forward
Fri, 21 Feb 2020 18:42:00 +0000
Oscar Health Cuts Co-Pays on About 100 Drugs to $3
Sun, 16 Feb 2020 15:00:00 +0000
Validea's Top Five Healthcare Stocks Based On Warren Buffett - 2/16/2020
Thu, 13 Feb 2020 13:00:00 +0000
Better Buy: Abbott Laboratories vs. Novo Nordisk
Sat, 08 Feb 2020 12:00:00 +0000
Is Amgen a Stock to Buy?
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
